Summary & Slides: Hepatitis C Drugs - Evidence to Demonstrate Effectiveness and Value

On July 7, 2014, the Green Park Collaborative (GPC) of the Center for Medical Technology Policy (CMTP) and the Institute for Clinical and Economic Review (ICER) co-hosted a web conference to explore the evidence needed to demonstrate the effectiveness and value of new drugs to treat chronic hepatitis C (HCV) infection.

Hepatitis C Drugs - Evidence to Demonstrate Effectiveness & Value from CMTP_Baltimore